Biotest AG
BIESF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,094,965 | $1,238,676 | $1,531,800 | $1,474,770 |
| - Cash | $107,800 | $108,100 | $116,600 | $104,400 |
| + Debt | $597,200 | $614,100 | $574,300 | $496,300 |
| Enterprise Value | $1,584,365 | $1,744,676 | $1,989,500 | $1,866,670 |
| Revenue | $726,200 | $684,600 | $516,100 | $515,600 |
| % Growth | 6.1% | 32.6% | 0.1% | – |
| Gross Profit | $223,800 | $280,300 | $124,900 | $80,700 |
| % Margin | 30.8% | 40.9% | 24.2% | 15.7% |
| EBITDA | $120,400 | $182,200 | $24,700 | -$18,300 |
| % Margin | 16.6% | 26.6% | 4.8% | -3.5% |
| Net Income | $26,400 | $127,000 | -$31,700 | -$63,400 |
| % Margin | 3.6% | 18.6% | -6.1% | -12.3% |
| EPS Diluted | 0.71 | 3.21 | -0.8 | -1.6 |
| % Growth | -77.9% | 501.2% | 50% | – |
| Operating Cash Flow | $60,900 | -$2,700 | -$40,500 | $33,900 |
| Capital Expenditures | -$28,700 | -$33,400 | -$29,300 | -$18,200 |
| Free Cash Flow | $32,200 | -$36,100 | -$69,800 | $15,700 |